|
|
|
|
|
|
|
20%
|
|
The portion of medical questions ChatGPT answered inappropriately, according to a 2024 Stanford University study. Seizing on healthcare, Microsoft is developing its own chatbot in collaboration with Harvard to reduce its reliance on OpenAI, ChatGPT's maker.
|
|
|
|
|
|
|
|
|
|
“Honey, I’m a nun, not a saint.”
|
|
— The late Sister Marion Irvine, who tried jogging in midlife, became a competitive runner, and even in her mid-90s walked 90 minutes a day. She also enjoyed vodka and cranberry juice.
|
|
|
|
|
|
|
|
|
|
|
|
PHOTO: ALLISON DINNER / EPA / SHUTTERSTOCK
|
|
|
|
|
|
How to get a Covid booster shot. The CDC’s Advisory Committee on Immunization Practices—a panel handpicked by RFK Jr.—no longer universally recommends the Covid vaccine. But it is possible many Americans can still receive the updated vaccine this fall.
|
|
|
The cost of aging in place. Millions of aging baby boomers who want to grow old at home will have to get their houses ready to age in place. The Journal created an interactive tool to help you plan ahead.
|
|
|
‘Crunchy Moms’ Have Stayed Away from Tylenol for Years. For “crunchy moms” cautious about over-the-counter drugs and others who have taken cues from the “Make America Healthy Again” movement, autism risk is just one more reason to avoid acetaminophen, the active ingredient in Tylenol.
|
|
|
Register for WSJ Future of Health. Join us for in-depth conversations tackling healthcare’s most pressing challenges and promising opportunities on November 3, 2025, in Washington, D.C. Request your invitation here.
|
|
|
|
|
|
|
|
President Trump last week announcing a deal to lower drug prices. PHOTO: WIN MCNAMEE / GETTY IMAGES
|
|
|
|
|
|
Trump wants to overhaul drug sales. His son could benefit. BlinkRx, an online prescription-drug delivery company, this year installed Donald Trump Jr. as a board member and now stands to benefit after President Trump urged pharmaceutical companies to sell medicines directly to consumers.
|
|
|
Amgen lowers cholesterol-medication price. After Trump called for price cuts, the biotechnology company launched AmgenNow, a direct-to-patient program, with its drug Repatha. The prescription medication used to lower "bad" cholesterol will cost $239 a month, about 60% lower than the current U.S. list price.
|
|
|
Generic drugs escape tariffs. The Trump administration said it isn’t planning to impose tariffs on generic drugs from foreign countries, but the move isn’t final and could change in the coming weeks.
|
|
|
|
|
This newsletter was compiled by the WSJ’s Health & Science team. Follow us on X @WSJHealth and @WSJScience. Email us by replying to this newsletter. Got a tip for us? Here's how to submit.
|
|
|
|
|
|
|
|
